BeingWell

A Medika Life Publication for the Medical Community

Member-only story

North Texas Obgyns Need to Know About Monoclonal Antibodies for Covid-19

Dr Jeff Livingston
BeingWell
Published in
4 min readAug 28, 2021

--

Photo: LSOphoto Istock Getty Images

The Covid-19 Delta variant continues to attack North Texas. It is time for community Obgyn physicians and providers to help the growing number of infected patients get access to effective and early treatment.

Monoclonal antibody therapy reduces the risk of hospitalization and severe disease. Pregnant people qualify for treatment, but they need to get the treatment as early as possible.

Our company, MacArthur Medical Center’s core values include INNOVATION and EXCELLENCE. We stay at the cutting edge to promote the best care possible to our patients.

Our company has started offering monoclonal antibody treatments to any pregnant patient who tests positive for Covid-19. We also refer gynecologic patients who meet the criteria.

We share this protocol to help other practices learn of this treatment’s value and to provide a roadmap to integrate a similar option inside of their own practice

--

--

BeingWell
BeingWell

Published in BeingWell

A Medika Life Publication for the Medical Community

Dr Jeff Livingston
Dr Jeff Livingston

Written by Dr Jeff Livingston

Obgyn, Husband, Father, & Entrepreneur. Writing about Women’s Health, Parenting, and Self-improvement. CEO of MacArthurmc.com & founder of Medika.life

No responses yet